ReviewFrontiers in immunology2024

Companion diagnostics and predictive biomarkers for PD-1/PD-L1 immune checkpoint inhibitors therapy in malignant melanoma.

Zeping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.